BE
BE · BE · BE-AMP-SAM162373-00
Videx D.D.I 2 g
ATC J05AF02
Last synced from FAMHP / AFMPS (Belgium) on
Identification
ManufacturerBristol-Myers Squibb Belgium
CountryBE (BE)
ATC codeJ05AF02
Dispensing—
ReimbursedNo
SourceFAMHP / AFMPS (Belgium)
Last synced6/13/2026
Packs · 2
- be_apb1077908
- be_apb0740688
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Oral powder",
"source": "afmps",
"status": "REVOKED",
"name_en": "Videx D.D.I 2 g",
"name_fr": "Videx D.D.I 2 g",
"name_nl": "Videx D.D.I 2 g",
"amp_code": "SAM162373-00",
"strengths": [
"2000.0000"
],
"pack_count": 1,
"substances": [
"Didanosine"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Didanosine",
"authorisation_numbers": [
"BE162373"
]
}Related drugs
Other records sharing ATC code J05AF02.
- FIVidexBristol-Myers Squibb Ab
- FIVidexBristol-Myers Squibb Ab
- FIVidexBristol-Myers Squibb Ab
- FIVidexBristol-Myers Squibb Ab
- FIVidexBristol-Myers Squibb Ab
- GBVidex 150mg chewable dispersible tabletsBristol-Myers Squibb Pharmaceuticals Ltd
- GBVidex 200mg chewable dispersible tabletsBristol-Myers Squibb Pharmaceuticals Ltd
- GBVidex 25mg chewable dispersible tabletsBristol-Myers Squibb Pharmaceuticals Ltd
Access this data programmatically
Query Videx D.D.I 2 g and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.